Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan

Pediatric Infectious Disease Journal

Volumn 22, Issue 7, 2003, Pages 584-588

  Yang, Yao Jong ^a   Liu, Ching Chuan ^a   Chen, Te Jen ^b   Lee, Meng Feng ^b   Chen, Sheng Hsien ^b   Shih, Hsiang Hung ^c   Chang, Mei Hwei ^d  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Hepatitis B e antigen; Hepatitis B immunoglobulin; Hepatitis B virus; Immunoprophylaxis; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B(E) ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; RECOMBIVAX B;

ACTIVE IMMUNIZATION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTECTION; SEROLOGY; TAIWAN; TREATMENT OUTCOME; VACCINATION; VERTICAL TRANSMISSION; VIRUS CARRIER; VIRUS TRANSMISSION;

CARRIER STATE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEROLOGIC TESTS; STATISTICS, NONPARAMETRIC; TAIWAN; TREATMENT OUTCOME;

EID: 0042845943     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200307000-00003     Document Type: Article

References (27)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. Lancet 1981;2:1129-33.
2. Chang MH, Lee CY, Chen DS, Hsu HC, Lai MY. Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus. J Pediatr 1987;111:34-9.
3. Esteban JI, Genesca J, Esteban R, et al. Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area. J Med Virol 1986;18:381-91.
4. Hsu HM, Chen DS, Chuang CH, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan: study on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 1988;260:2231-5.
5. Beasley RP, Hwang LY, Lee GCY, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-102.
6. Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carrier of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Lancet 1984;1:921-6.
7. Chen DS, Hsu NHM, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-603.
8. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-8.
9. Shih HH, Chang MH, Hsu HY, et al. Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan. Pediatr Infect Dis J 1999;18:427-32.
10. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997;336:1855-9.
11. Lin HH, Hsu HY, Lee TY, Hsieh RP, Chen PJ, Chen DS. Age-specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. Asia-Oceania J Obstet Gynaecol 1994;20:141-5.
12. Lu SN, Liu JH, Wang JH, Lu CC. Secular trends of HBeAg prevalence among HBsAg-positive delivery mothers in a hepatitis B endemic area. J Trop Pediatr 2000;46:121-3.
13. Hsu HY, Chang MH, Lee CY, et al. Precore mutant of hepatitis B virus in childhood fulminant hepatitis B: an infrequent association. J Infect Dis 1995;171:776-81.
14. Cheng CN, Liu CC, Wang SM, Yang YJ, Yang HB. Fulminant hepatitis B in young infants who had received hepatitis B vaccination [Abstract]. Acta Paediatr Sin 1997;38(Suppl B):152-3.
15. Chen HL, Chang MH, Chang CJ, et al. Fulminant hepatic failure in children in endemic area of hepatitis B infection: 15 years after universal hepatitis B vaccination [Abstract 26]. Presented at the 314th Scientific Meeting of the Taiwan Pediatric Society, Taipei, April 13 to 14, 2002.
16. Tong MJ, Sinatra FR, Thomas DW, Nair PV, Merritt RJ, Wang DW. Need for immunoprophylaxis in infants born to HBsAg-positive carrier mothers who are HBeAg negative. J Pediatr 1984;105:945-7.
17. Mazel JA, Schalm SW, de Gast BC, et al. Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations. Br Med J Clin Res Ed 1984;288:513-5.
18. Rosendahl C, Kochen MM, Kretschmer R, Wegscheider K, Kaiser D. Avoidance of perinatal transmission of hepatitis B virus: is passive immunization always necessary? Lancet 1983;1:1127-9.
19. Sangfelt P, Reichard O, Lidman K, Von Sydow M, Forsgren M. Prevention of hepatitis B by immunization of the newborn infant: a long-term follow-up study in Stockholm, Sweden. Scand J Infect Dis 1995;27:3-7.
20. Barbara JA, Howell DR, Contreras M, et al. Indications for hepatitis B immunoglobulin for neonates of HBsAg carrier mothers. Br Med J Clin Res Ed 1984;289:880.
21. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-4.
22. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94-8.
23. Huang YS, Liu CC, Wang SM, Lei HY. Seroepidemiology of hepatitis B virus infection in southern Taiwan: 15 years after hepatitis B mass vaccination [Abstract 82]. Presented at the 10th Asian Pediatric Congress, Taipei, Taiwan, March 26 to 30, 2000.
24. Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983;147:185-90.
25. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-9.
26. Milne A, West DJ, Chinh DV, Moyes CD and Poerschke G. Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants. J Med Virol 2002;67:327-33.
27. Lolekha S, Warachit B, Hirunyachote A, et al. Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand. Vaccine 2002;20:3739-43.